MULTIDRUG RESISTANCE PROTEINS OF THE ABCC SUBFAMILY - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 303

110. Lee YM, Cui Y, Konig J, Risch A, Jager B, Drings P, Bartsch H, Keppler D, Nies AT. 2004.
Identification and functional characterization of the natural variant MRP3-Arg1297His of
human multidrug resistance protein 3 (MRP3/ABCC3). Pharmacogenetics 14:213-223.
111. Akita H, Suzuki H, Hirohashi T, Takikawa H, Sugiyama Y. 2002. Transport activity of
human MRP3 expressed in Sf9 cells: comparative studies with rat MRP3. Pharm Res
19:34-41.
112. Zeng H, Bain LJ, Belinsky MG, Kruh GD. 1999. Expression of multidrug resistance
protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293
cells confers resistance to anticancer agents. Cancer Res 59:5964-5967.
113. Zeng H, Chen ZS, Belinsky MG, Rea PA, Kruh GD. 2001. Transport of methotrexate
(MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of poly-
glutamylation on MTX transport. Cancer Res 61:7225-7232.
114. Schuetz JD, Connelly MC, Sun D, Paibir SG, Flynn PM, Srinivas RV, Kumar A, Frid-
land A. 1999. MRP4: A previously unidentified factor in resistance to nucleoside-based
antiviral drugs. Nat Med 5:1048-1051.
115. Lee K, Klein-Szanto AJ, Kruh GD. 2000. Analysis of the MRP4 drug resistance profile
in transfected NIH3T3 cells. J Natl Cancer Inst 92:1934-1940.
116. Chen ZS, Lee K, Kruh GD. 2001. Transport of cyclic nucleotides and estradiol 17-beta-
D-glucuronide by multidrug resistance protein 4: resistance to 6-mercaptopurine and
6-thioguanine. J Biol Chem 276:33747-33754.
117. Adachi M, Sampath J, Lan LB, Sun D, Hargrove P, Flatley R, Tatum A, Edwards MZ,
Wezeman M, Matherly L, Drake R, Schuetz J. 2002. Expression of MRP4 confers resis-
tance to ganciclovir and compromises bystander cell killing. J Biol Chem 277:38998-
39004.
118. Jedlitschky G, Tirschmann K, Lubenow LE, Nieuwenhuis HK, Akkerman JW, Greinacher
A, Kroemer HK. 2004. The nucleotide transporter MRP4 (ABCC4) is highly expressed
in human platelets and present in dense granules, indicating a role in mediator storage.
Blood 104:3603-3610.
119. Chen ZS, Lee K, Walther S, Raftogianis RB, Kuwano M, Zeng H, Kruh GD. 2002.
Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4):
MRP4 is a component of the methotrexate efflux system. Cancer Res 62:3144-3150.
120. Zelcer N, Reid G, Wielinga P, Kuil A, van der Heijden, I, Schuetz JD, Borst P. 2003.
Steroid and bile acid conjugates are substrates of human multidrug-resistance protein
(MRP) 4 (ATP-binding cassette C4). Biochem J 371:361-367.
121. Reid G, Wielinga P, Zelcer N, van der Heijden, I, Kuil A, de Haas M, Wijnholds J, Borst P.
2003. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux
transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci
U S A 100:9244-9249.
122. Rius M, Thon WF, Keppler D, Nies AT. 2005. Prostanoid transport by multidrug resistance
protein 4 (MRP4/ABCC4) localized in tissues of the human urogenital tract. J Urol
174:2409-2414.
123. Rius M, Hummel-Eisenbeiss J, Hofmann AF, Keppler D. 2006. Substrate specificity of
human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione. Am
J Physiol Gastrointest Liver Physiol 290:G640-G649.
124. van Aubel RA, Smeets PH, van den Heuvel JJ, Russel FG. 2005. Human organic an-
ion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate